MDxHealth SA (MDXH) vs T2 Biosystems, Inc. (TTOO)

MDxHealth SA and T2 Biosystems, Inc. are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $14.4M against $6.5M — 2.2× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against −30.2%. MDxHealth SA has the higher net margin (−32.5% vs −559.5%) and the lower return on invested capital (−23.8% vs 0.00%). Across the 16 metrics below, MDxHealth SA leads on 11 and T2 Biosystems, Inc. on 5.

Valuation

Metric MDXH TTOO Diagnostics & Research median
P/E n/m n/m 34.52
P/S 0.07 n/m 4.24
P/B n/m n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 0.81 6.26 5.18
Earnings yield (480.00%) 0.00% (1.50%)
Free cash flow yield (88.89%) 0.00% 0.00%

Profitability

Metric MDXH TTOO Diagnostics & Research median
Gross margin 63.23% (76.76%) 48.32%
Operating margin (18.04%) (542.59%) (5.68%)
Net margin (32.53%) (559.52%) (4.10%)
Free cash flow margin (5.24%) (476.64%) 0.00%
Return on equity 238.67% 277.61% 0.00%
Return on assets (27.38%) (140.00%) (6.05%)
Return on invested capital (23.77%) 0.00% 0.00%

Growth

Metric MDXH TTOO Diagnostics & Research median
Revenue growth (TTM) 21.46% (30.19%) 8.99%
EPS growth (last fiscal year) 42.24% 98.44% 20.36%
Revenue growth, 5-year CAGR 42.34% (7.29%) 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXH TTOO Diagnostics & Research median
Debt to equity (3.42) 0.00 0.01
Current ratio 1.15 0.40 2.27
Net debt to EBITDA (10.71) 0.32 0.68

Dividend

Metric MDXH TTOO Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric MDXH TTOO Diagnostics & Research median
Market cap 14.40m 6.48m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack